Effect of rofecoxib on platelet aggregation and blood loss in gynaecological and breast surgery compared with diclofenac.
D000328:Adult; D000368:Aged; D000701:Analgesics, Opioid / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology*; D000932:Antiemetics / Q000627:therapeutic use; D016063:Blood Loss, Surgical / Q000517:prevention & control*; D001943:Breast Neoplasms / Q000601:surgery*; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology*; D004008:Diclofenac / Q000494:pharmacology*; D004311:Double-Blind Method; D005260:Female; D006488:Hemostasis, Surgical / Q000379:methods; D006801:Humans; D007044:Hysterectomy; D007783:Lactones / Q000494:pharmacology*; D008875:Middle Aged; D009020:Morphine / Q000627:therapeutic use; D010147:Pain Measurement; D010974:Platelet Aggregation / Q000187:drug effects*; D011247:Pregnancy; D011446:Prospective Studies; D013450:Sulfones; D016896:Treatment Outcome
D000701:Analgesics, Opioid; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000932:Antiemetics; D016861:Cyclooxygenase Inhibitors; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib; D004008:Diclofenac; D009020:Morphine